James, appreciate the positive outlooks, however as most here are aware, we heard/read similar positivity after public offerings of Advaxis to raise 20 million or so.. more than once.. and we all know how that one ended.. (countless times people said this is the bottom and the only way was up, which was all a big lie) So, what’s the guarantee (or at least a clue?) with OncoSec, having Dan on the helm, to not be fooled again and get sucked in to further traps in the land of shady looking baby bio arena?